Primary Antibodies
Secondary Antibodies
Proteins & Peptides
ELISA Kits
About Us
Contact Us
Sign In/Register
0
ISO 9001:2015 Certified
Live Customer Support
4.5/5 on Trustpilot
100% Quality Guarantee
Home
Primary Antibodies
TFPI Antibodies
Concizumab Biosimilar - Anti-TFPI Antibody (PE) (A334258)
Concizumab Biosimilar - Anti-TFPI Antibody (PE) (A334258)
Overview
Specifications
Recombinant Antibody
$349
Product Datasheet
Recombinant humanized monoclonal antibody to TFPI (PE) for Flow Cytometry.
100% Guarantee
Price Match Guarantee
Product Size:
100T
Quantity:
1
2
3
4
5
6
7
8
9
10
Add To Cart
Request a Quotation
Custom or Bulk Request
Shipping Information
Freight/Packing Charges:
$40
Dispatched from St. Louis, MO.
Lead Time: 7-10 business days.
Tags:
Recombinant Antibody
Specifications
Name
Concizumab Biosimilar - Anti-TFPI Antibody (PE)
Description
Recombinant humanized monoclonal antibody to TFPI (PE).
Applications
Flow Cytometry
Dilutions
Flow Cytometry: 1:100
Reactivity
Human
Host
Humanized
Clonality
Monoclonal
Isotype
IgG4
Conjugate
PE
Excitation: 565nm, Emission: 578nm
Purification
Affinity chromatography.
Concentration
Lot Specific
Product Form
Liquid
Formulation
Supplied in Phosphate Buffered Saline with 0.05% Proclin 300 and 1% BSA.
Storage
Store at 4°C. Do not freeze!
Synonyms
EPI, Extrinsic pathway inhibitor, LACI, Lipoprotein-associated coagulation inhibitor, TFPI1, Tissue factor pathway inhibitor
Disclaimer
This product is for research use only. It is not intended for diagnostic or therapeutic use.
Publishing research using Concizumab Biosimilar - Anti-TFPI Antibody (PE) (A334258)? Please
let us know
so that we can list the citation on this page.
Alternative products to Concizumab Biosimilar - Anti-TFPI Antibody (PE) (A334258)
A334257
Befovacimab Biosimilar - Anti-TFPI Antibody (PE)
Recombinant humanized monoclonal antibody to TFPI (PE) for Flow Cytometry.
A334257
Befovacimab Biosimilar - Anti-TFPI Antibody (PE)
Recombinant humanized monoclonal antibody to TFPI (PE) for Flow Cytometry.
Proteins predicted to interact with TFPI
Predicted protein interactions based upon String database. Revelancy score correlates with probability of interaction.
Factor X Antibodies
99.9% Relevancy Score
Tissue Factor Antibodies
99.9% Relevancy Score
Factor VII Antibodies
99.5% Relevancy Score
Thrombomodulin Antibodies
96.3% Relevancy Score
Prothrombin Antibodies
94% Relevancy Score
Antithrombin III Antibodies
93.9% Relevancy Score
Heparin Cofactor II Antibodies
88.4% Relevancy Score
EPCR Antibodies
86% Relevancy Score
Plasminogen Antibodies
81.5% Relevancy Score
Top
